These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3841586)

  • 21. Influence of misonidazole on the radiosensitivity of transplantable transitional cell bladder carcinoma in mice.
    Hampel N; Persky L
    Invest Urol; 1981 Jul; 19(1):14-6. PubMed ID: 7251317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
    Siemann DW; Alliet K; Maddison K; Wolf K
    Cancer Treat Rep; 1985 Dec; 69(12):1409-14. PubMed ID: 3841024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship between the radiosensitizing effect of mecytosine, the timing of its application and the fractionation of the radiation dose].
    Aleksandrov SN; Vershinina SF
    Med Radiol (Mosk); 1972 May; 17(5):36-8. PubMed ID: 5051071
    [No Abstract]   [Full Text] [Related]  

  • 24. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
    Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
    Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials of radiosensitizers: what should we expect?
    Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):425-9. PubMed ID: 6231272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo.
    Denekamp J; Michael BD; Harris SR
    Radiat Res; 1974 Oct; 60(1):119-32. PubMed ID: 10881705
    [No Abstract]   [Full Text] [Related]  

  • 27. Radiosensitizing and cytocidal effects of misonidazole: evidence for separate modes of action.
    Hofer KG; Friedland JL; Dynlacht J; Hofer MG
    Radiat Res; 1987 Jul; 111(1):130-42. PubMed ID: 3602350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic and radiosensitizing effect of the 2-nitroimidazole misonidazole (Ro-07-0582) on murine CFU in vivo.
    Pettersen EO
    Br J Cancer Suppl; 1978 Jun; 3():107-10. PubMed ID: 277208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
    Rockwell S
    Br J Cancer Suppl; 1978 Jun; 3():212-5. PubMed ID: 277230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular absorption and toxicity of a radiosensitizer and its effect on hypoxic cells.
    Rootman J; Josephy PD; Adomat H; Palcic B
    Arch Ophthalmol; 1982 Mar; 100(3):468-71. PubMed ID: 7199901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of misonidazole (Ro-07-0582) on the incidence of micronuclei in irradiated Ehrlich tumour ascites cells.
    Olinici CD; Mustea I
    Int J Radiat Biol Relat Stud Phys Chem Med; 1978 Dec; 34(6):589-93. PubMed ID: 311764
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of X-ray-induced potentially lethal damage (PLD) repair in aerobic plateau-phase Chinese hamster cells by misonidazole.
    Brown DM; Dionet C; Brown JM
    Radiat Res; 1984 Jan; 97(1):162-70. PubMed ID: 6229806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Radiosensitizing effect of a 2-nitroimidazole hydroxamate (KIN-804) to murine tumors].
    Tada T; Nakajima T; Onoyama Y; Nagasawa H; Hori H; Inayama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):688-90. PubMed ID: 1508643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postirradiation modification of tumor blood flow: a method to increase the effectiveness of chemical radiosensitizers.
    Chaplin DJ
    Radiat Res; 1988 Aug; 115(2):292-302. PubMed ID: 3406369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of acidic pH on radiosensitization of FSaIIC cells in vitro by misonidazole, etanidazole, or cis-diamminedichloroplatinum (II).
    Herman TS; Teicher BA; Pfeffer MR; Khandekar V; Chapnick RM; Kalick GS; Rabow A
    Radiat Res; 1990 Oct; 124(1):28-33. PubMed ID: 2146699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radiosensitizing and damaging effects of hyperthermia on different biological systems. Ehrlich ascites carcinoma cells].
    Shteĭn LV; Konopliannikov AG
    Radiobiologiia; 1983; 23(6):770-3. PubMed ID: 6361843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radiosensitizing and toxic action of metronidazole and isometronidazole (1-(2-hydroxyethyl)-2-methyl-4-nitroimidazole) on the cells of Ehrlich ascites cancer and hemoblastosis La in vitro].
    Proskuriakov SIa; Smoryzanova OA; Dedenkov AN; Riabchenko NI
    Radiobiologiia; 1986; 26(6):766-70. PubMed ID: 3809411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the mechanisms of the radiosensitizing and cytotoxic properties of RSU-1069 and its analogues.
    Walling JM; Stratford IJ; Adams GE; Silver AR; Ahmed I; Jenkins TC; Fielden EM
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1083-6. PubMed ID: 3755712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitizers: rationale and potential.
    Brown JM
    Cancer Treat Rep; 1981; 65 Suppl 2():95-102. PubMed ID: 7346152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.